project id: TCGA-GBM; case submitter id: TCGA-16-1062; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.8; spectrophotometer method: UV Spec; age at index: 57; days to birth: -21148; days to death: 646; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1949; year of death: 2007; age at diagnosis: 21148; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 556.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; portion number: 01; weight: 99.0; composition: Not Reported; intermediate dimension: 0.8; longest dimension: 1.0; preservation method: Unknown; shortest dimension: 0.2; sample id: 69325ba7-4b7c-41a6-897e-ad21c573fa3f; sample submitter id: TCGA-16-1062-01A; portion id: 214acd7a-5b7b-4111-bf10-10a2aa48283a; portion submitter id: TCGA-16-1062-01A-01; percent lymphocyte infiltration: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent tumor nuclei: 90.0;